Brain temperature regulation in poor-grade subarachnoid hemorrhage
patients – A multimodal neuromonitoring study |
| |
Authors: | Alberto Addis,Maxime Gaasch,Alois J Schiefecker,Mario Kofler,Bogdan Ianosi,Verena Rass,Anna Lindner,Gregor Broessner,Ronny Beer,Bettina Pfausler,Claudius Thom ,Erich Schmutzhard,Raimund Helbok |
| |
Affiliation: | 1.Neuro-Intensive Care Unit, Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria;2.Neurology, Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy;3.School of Medicine, University of Milan-Bicocca, Milano, Italy;4.Department of Neurosurgery, Medical University of Innsbruck, Innsbruck, Austria |
| |
Abstract: | Elevated body temperature (Tcore) is associated with poor outcome after subarachnoid hemorrhage (SAH). Brain temperature (Tbrain) is usually higher than Tcore. However, the implication of this difference (Tdelta) remains unclear. We aimed to study factors associated with higher Tdelta and its association with outcome. We included 46 SAH patients undergoing multimodal neuromonitoring, for a total of 7879 h of averaged data of Tcore, Tbrain, cerebral blood flow, cerebral perfusion pressure, intracranial pressure and cerebral metabolism (CMD). Three-months good functional outcome was defined as modified Rankin Scale ≤2. Tbrain was tightly correlated with Tcore (r = 0.948, p < 0.01), and was higher in 73.7% of neuromonitoring time (Tdelta +0.18°C, IQR −0.01 – 0.37°C). A higher Tdelta was associated with better metabolic state, indicated by lower CMD-glutamate (p = 0.003) and CMD-lactate (p < 0.001), and lower risk of mitochondrial dysfunction (MD) (OR = 0.2, p < 0.001). During MD, Tdelta was significantly lower (0°C, IQR −0.2 – 0.1; p < 0.001). A higher Tdelta was associated with improved outcome (OR = 7.7, p = 0.002). Our study suggests that Tbrain is associated with brain metabolic activity and exceeds Tcore when mitochondrial function is preserved. Further studies are needed to understand how Tdelta may serve as a surrogate marker for brain function and predict clinical course and outcome after SAH. |
| |
Keywords: | Subarachnoid haemorrhage outcome studies microdialysis neurocritical care clinical practice |
|
|